A new research reveals that commonly used drugs to treat type II diabetes mitigate the characteristic signs of nicotine withdrawal in rats and mice. The finding may offer an important new strategy in the battle to quit smoking. The results of the study were published in the Journal of Neuroscience 2019. Smokers trying to quit face potent side effects from nicotine withdrawal including cravings increased appetite restlessness anxiety irritability and depression. Even though they may want to quit many smokers continue to smoke simply because the experience is so unpleasant. The diabetes drug pioglitazone targets a specific form of the
